Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for...

Here is Think IP Strategy’s weekly selection of top intellectual property news breaking in the blogosphere and internet. Highlights this week included: Final ACTA draft ready for review (IAM) (IP Watch)...

Here is Think IP Strategy’s weekly selection of top Online intellectual property news breaking in the blogosphere and internet. Highlights this week included: Near final ACTA text released – shows US...

When was the last time you saw a mess like this? Thanks to Ars Technica for the insightful write up as always. Or, to look at it another way (from information...

Ever had questions about the reliability of your IP competitive intelligence reports? As mentioned in passing in earlier posts, IP can be used as a competitive intelligence tool to gain insight...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. Highlights this week included: Prezista (Darunavir) – US NIH becomes...

1.  IP is not just another expense. 2.  IP is an asset – decide on a way to account for it as such – and keep up with the debate about...

Here is Think IP Strategy’s weekly selection of top intellectual property news breaking in the blogosphere and internet. Highlights this week included: New president for OHIM (Class 46) (Class 99) Council...

Here is Think IP Strategy’s weekly selection of top Online intellectual property news breaking in the blogosphere and internet. Highlights this week included:   Spain: YouTube not liable for user uploads...